RECRUITING

Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators plan to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following hip arthroscopy. BFR has shown to be great at helping the recovery process. SAGA is a well-known smart training technology company, and the investigators aim to partner with SAGA to use the BFR cuffs as the intervention method. The BFR cuff will be added to the current SOC for hip scope PT for the intervention group.

Official Title

Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation

Quick Facts

Study Start:2022-04-29
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05165927

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * patients with labral tears, femoroacetabular impingement syndrome, loose bodies, ligamentum teres tears, and related intra-articular pathology to be treated with hip arthroscopy. Patients must also have access to a smartphone device in order to utilize the SAGA BFR application for use. The application is free to use.
  1. * bilateral hip surgeries to be performed within 12 weeks of each other, concomitant Peri-acetabular osteotomy, soft tissue repairs (hamstring, glute repairs), clinically diagnosed hip dysplasia, and the following BFR contraindications:
  2. * Deep Vein Thrombosis (DVT)
  3. * Pulmonary Embolism
  4. * Hemorrhagic/Thrombolytic Stroke
  5. * Clotting Disorders
  6. * Hemophilia or taking blood thinners
  7. * Pregnant or up to 6 months post-partum
  8. * Untreated Hypertension
  9. * Untreated Hypotension
  10. * Rhabdomyolysis or recent traumatic injury

Contacts and Locations

Study Contact

Lauren M Heylmun, BS
CONTACT
7205169823
lauren.heylmun@cuanschutz.edu

Principal Investigator

James Genuario, MD
PRINCIPAL_INVESTIGATOR
University of Colorado SOM

Study Locations (Sites)

UCHealth Steadman Hawkins Clinic Denver
Englewood, Colorado, 80012
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • James Genuario, MD, PRINCIPAL_INVESTIGATOR, University of Colorado SOM

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-29
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2022-04-29
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Hip Injuries